Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-I
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2024, Vol 5, Issue 2
Abstract
Mesenchymal stem cells hold many therapeutic benefits in treating diverse disease states, but autologous requirements, high costs, lack of standardization and other factors limit their widespread application. Additionally, researchers have discovered that many mesenchymal stem cell in-vivo benefits originate from their paracrine factors. Therefore, cell-free therapeutics, including mesenchymal stem cell-derived conditioned medium and extracellular vesicles have been suggested as alternative bioregenerative therapies. This literature review summarizes mesenchymal stem cell application, the benefits of cell-free strategies and the components of its secretome. This manuscript is a companion piece to “Part 2: Bioregenerative Applications of the Human Mesenchymal Stem Cell-Derived Secretome,” included in this issue, which contains the results of in-vivo studies applying the conditioned medium and extracellular vesicles to human and animal models, ongoing clinical trials, limitations to cell-free strategies and future directions for the wide-scale adoption of these therapies.
Authors and Affiliations
Matthew Keagle1, Vincent S Gallicchio2*
A Gout Flare Caused by the Administration of Platelet Rich Plasma: A Clinical Case
The therapy with Platelet Rich Plasma (PRP) administered in degenerated or injured musculoskeletal tissues is a new and promising regenerative treatment option. Traditionally, it is considered that as PRP represents an a...
A Porcine Model for Repair of Long Bone Non-Union Defects Using Three-Dimensionally Printed Scaffolds
Background: Approximately 5-10% of bone injuries in the United States result in non-union, costing an estimated $10.4-26.1 billion annually for treatment. While several orthopedic strategies to address non-unions in lo...
Adipose-Derived Stem Migration in the Vascular System after Transplantation and the Potential Colonization of Ectopic Sites in Swine
Background: Adipose-derived Stem Cells (ASC) are obtained from adipose tissue. They can be harvested by liposuction under local anesthesia, making these cells particularly desirable for use in tissue engineering or cel...
Costus Afer Stem Juice Extract Enhances Wound Healing Process Through the Modulation of the Expression of TGF-Β1 at Wound Site
Recent studies have explored the potential of Costus afer stem juice in supporting the process of tissue repair and regeneration. This study sought to expand on those discoveries by assessing the expression of transformi...
Use of Stem Cells to Treat Left Ventricular Hypertrophy
Left Ventricular Hypertrophy is a multifactorial condition involving genetic and signaling pathways. Current recommendations for treating hypertensive LVH include ACE inhibitors, RAS and CCBs. Despite numerous drug thera...